![Cue Biopharma Inc](/common/images/company/N_CUE.png)
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
BOSTON, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage...
Prioritizing autoimmune programs aims to focus upon near-term and intermediate value creation potential, while retaining oncology programs as promising clinical data continues to mature - Company...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2 | -22.2222222222 | 0.9 | 1 | 0.7 | 278655 | 0.8049145 | CS |
4 | -0.05 | -6.66666666667 | 0.75 | 1 | 0.583 | 274126 | 0.76329782 | CS |
12 | -0.88 | -55.6962025316 | 1.58 | 1.75 | 0.583 | 417745 | 0.93491635 | CS |
26 | -1.63 | -69.9570815451 | 2.33 | 2.358 | 0.583 | 340695 | 1.32825688 | CS |
52 | -2.07 | -74.7292418773 | 2.77 | 3.2491 | 0.583 | 322981 | 1.88370034 | CS |
156 | -11.76 | -94.3820224719 | 12.46 | 18.42 | 0.583 | 320022 | 4.52604426 | CS |
260 | -6.78 | -90.6417112299 | 7.48 | 35.5 | 0.583 | 305192 | 8.82392834 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.